首页|期刊导航|中国普通外科杂志|局部切除术在中低位直肠癌新辅助放化疗后临床完全缓解或近完全缓解患者中的应用

局部切除术在中低位直肠癌新辅助放化疗后临床完全缓解或近完全缓解患者中的应用OA北大核心

Application of local resection in patients with mid-to-low rectal cancer achieving clinical complete or near-complete response after neoadjuvant chemoradiotherapy

中文摘要英文摘要

背景与目的:对于新辅助放化疗(nCRT)后达到临床完全缓解(cCR)或近cCR的中低位直肠癌患者,如何在不显著降低肿瘤学预后的同时尽可能保留肛门功能成为医生和患者共同关注的焦点.本研究探讨在cCR或近cCR的直肠癌患者中使用局部切除术作为保留肛门的方法的安全性与可行性. 方法:回顾性分析2014年3月-2023年7月在中国医学科学院北京协和医院51例nCRT后达到cCR或近cCR并行局部切除术的中低位直肠癌患者的临床特征、影像学和病理学表现、手术结果、肿瘤学和功能结果. 结果:51例患者中男性34例,女性17例;平均年龄(61±14)岁.nCRT前影像学分期cT1~2N012 例(23.5%)、cT3N0 13 例(25.5%)、cT1~3N0~1 19 例(37.4%),cT1~3N2 7例(13.7%);肿瘤平均距肛门距离为(4.5±1.1)cm.nCRT后均达到cCR或近cCR,并接受了局部切除手术,其中40例(78.4%)行经肛门内镜显微手术(TEM)、7例(13.7%)行经肛门微创手术(TAMIS),4例(7.8%)行传统经肛门局部切除术.术后并发症发生率为27.5%(14/51),其中Clavien-Dindo并发症分级Ⅰ级比例为71.4%.术后组织学显示,ypT0 26 例(51.0%),ypT1 8 例(15.7%),ypT2 16 例(31.4%),ypT3 1 例(2.0%);病理结果与术前影像一致率为54.9%.中位随访时间60(34~79)个月,观察到4例(7.8%)局部复发、12例(23.5%)远处转移和5例(9.8%)因病死亡.术后6个月时Wexner评分和低位前切除综合征(LARS)评分均较 nCRT 后明显下降[Wexner:1(0~2)vs.2(1~5);LARS:3.3±5.75 vs.4.3±6.86,均 P<0.01]. 结论:nCRT后实现cCR或近cCR的中低位直肠癌患者采取局部切除术整块切除肠壁病灶,可准确判断肿瘤残留情况,有利于指导患者后续治疗,使部分患者避免根治性手术.对于难以耐受根治性手术或保肛意愿强烈的患者,采用局部切除术,可保留器官并保留肛门功能.但局部切除术并不能代替根治性手术,其确切的适应证仍需进一步深入探索.

Background and Aims:For patients with mid-to-low rectal cancer who achieve clinical complete response(cCR)or near-cCR after neoadjuvant chemoradiotherapy(nCRT),the key concern for both clinicians and patients is how to preserve anal function as much as possible without significantly compromising oncological outcomes.This study was performed to evaluate the safety and feasibility of local excision as an anus-preserving approach in rectal cancer patients with cCR or near-cCR. Methods:A retrospective analysis was conducted on 51 patients with mid-to-low rectal cancer who underwent local resection after achieving cCR or near-cCR following nCRT at Peking Union Medical College Hospital,Chinese Academy of Medical Sciences,between March 2014 and July 2023.The clinical characteristics,imaging and pathological findings,surgical outcomes,as well as oncological and functional results were reviewed. Results:Among the 51 patients,34 were male and 17 were female,with a mean age of 61±14 years.Pre-nCRT imaging staging showed:cT1-2N0 in 12 cases(23.5%),cT3N0 in 13 cases(25.5%),cT1-3N0-1 in 19 cases(37.4%),and cT1-3N2 in 7 cases(13.7%).The average tumor distance from the anal verge was(4.5±1.1)cm.After achieving cCR or near-cCR following nCRT,all patients underwent local resection:40 cases(78.4%)underwent transanal endoscopic microsurgery(TEM),7 cases(13.7%)underwent transanal minimally invasive surgery(TAMIS),and 4 cases(7.8%)underwent conventional transanal local excision.The postoperative complication rate was 27.5%(14/51),with 71.4%classified as Clavien-Dindo grade Ⅰ.Postoperative histopathology showed ypT0 in 26 cases(51.0%),ypT1 in 8 cases(15.7%),ypT2 in 16 cases(31.4%),and ypT3 in 1 case(2.0%).The concordance rate between pathological results and preoperative imaging was 54.9%.Over a median follow-up of 60 months(range:34-79),there were 4 cases(7.8%)of local recurrence,12 cases(23.5%)of distant metastasis,and 5 cancer-related deaths(9.8%).Six months postoperatively,both the Wexner score and the low anterior resection syndrome(LARS)score significantly improved compared to post-nCRT values[Wexner:1(0-2)vs.2(1-5);LARS:3.3±5.75 vs.4.3±6.86;both P<0.01]. Conclusion:For patients with mid-to-low rectal cancer who achieve cCR or near-cCR after nCRT,local en bloc resection of the bowel wall lesions enables accurate assessment of residual tumor status and facilitates personalized subsequent treatment,potentially sparing some patients from radical surgery.Local resection can be a viable anus-preserving option for patients who are unfit for or strongly averse to radical resection.However,local excision cannot replace radical surgery,and its precise indications warrant further investigation.

邱小原;周皎琳;林国乐;陆君阳;牛备战;邱辉忠

中国医学科学院北京协和医学院,北京 100730||中国医学科学院北京协和医院基本外科,北京 100730中国医学科学院北京协和医院基本外科,北京 100730中国医学科学院北京协和医院基本外科,北京 100730中国医学科学院北京协和医院基本外科,北京 100730中国医学科学院北京协和医院基本外科,北京 100730中国医学科学院北京协和医院基本外科,北京 100730

临床医学

直肠肿瘤放化疗,辅助经肛门内镜手术

Rectal NeoplasmsChemoradiotherapy,AdjuvantTransanal Endoscopic Surgery

《中国普通外科杂志》 2025 (4)

760-768,9

中央高水平医院临床科研专项基金资助项目[2022-PUMCH-C-005].

10.7659/j.issn.1005-6947.240110

评论